Skip to main content
Journal cover image

Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance?

Publication ,  Journal Article
Bazhenova, L; Urbanic, J; Onaitis, M
Published in: J Thorac Cardiovasc Surg
September 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

September 2021

Volume

162

Issue

3

Start / End Page

676 / 677

Location

United States

Related Subject Headings

  • Respiratory System
  • Prognosis
  • Mutation
  • Lung Neoplasms
  • Humans
  • ErbB Receptors
  • Carcinoma, Non-Small-Cell Lung
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bazhenova, L., Urbanic, J., & Onaitis, M. (2021). Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance? J Thorac Cardiovasc Surg, 162(3), 676–677. https://doi.org/10.1016/j.jtcvs.2020.06.109
Bazhenova, Lyudmila, James Urbanic, and Mark Onaitis. “Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance?J Thorac Cardiovasc Surg 162, no. 3 (September 2021): 676–77. https://doi.org/10.1016/j.jtcvs.2020.06.109.
Bazhenova L, Urbanic J, Onaitis M. Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance? J Thorac Cardiovasc Surg. 2021 Sep;162(3):676–7.
Bazhenova, Lyudmila, et al. “Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance?J Thorac Cardiovasc Surg, vol. 162, no. 3, Sept. 2021, pp. 676–77. Pubmed, doi:10.1016/j.jtcvs.2020.06.109.
Bazhenova L, Urbanic J, Onaitis M. Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance? J Thorac Cardiovasc Surg. 2021 Sep;162(3):676–677.
Journal cover image

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

September 2021

Volume

162

Issue

3

Start / End Page

676 / 677

Location

United States

Related Subject Headings

  • Respiratory System
  • Prognosis
  • Mutation
  • Lung Neoplasms
  • Humans
  • ErbB Receptors
  • Carcinoma, Non-Small-Cell Lung
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences